PRIA Logo™

The hidden hand

The tobacco plant healing human wounds

CollPlant engineers transgenic tobacco to produce recombinant human collagen, the protein that comprises 30% of the human body.

The number

30% of human body composition

The same plant engineered to cause cancer is now being modified to grow structurally identical Type I collagen with zero prion risk and no animal allergens. CollPlant's recombinant approach bypasses religious compliance issues while scaling toward commercial medical device volumes.

Source: CollPlant Engineers Tobacco Plants to Produce Human Collagen · Labiotech · Jan 1, 2024

Jump into the supply map

Where this story connects

The supplymap lets you trace the goods, inputs, and companies this story touches — see the full dependency chain, country shares, and historical incidents.

More on Supply input · Medical-Grade Atelocollagen (Wound Care / Bone Regeneration / Device OEM)

Related stories